Comparison of Plateletpheresis on Three Continuous Flow Cell Separators
Overview
Authors
Affiliations
Introduction: Platelet concentrate (PC) remains one of the most important support measures in thrombocytopenic patients. An efficient cell separator is a prerequisite for an optimally functioning apheresis setup. Donor blood count may undergo a temporary reduction after the procedure.
Aim: The aim was to find the extent of reduction in donor blood count (hemoglobin, hematocrit, white blood cell, and platelet) after plateletpheresis and to evaluate the cell separator for collection efficiency, processing time, and leukoreduction.
Study Design And Methods: Two hundred and thirty seven procedures performed on the Amicus (N = 121), Fenwal CS-3000 Plus (N = 50) and Cobe spectra (N = 66) in a one year period were evaluated. The procedures performed on the continuous flow centrifugation (CFC) cell separators and donor blood counts (pre and post donation) done were included in the study.
Results: The percent reduction in hemoglobin (HB), hematocrit (HCT), white blood cell (WBC) and platelet count ((PLT ct) was 2.9, 3.1, 9, 30.7 (Mean, N = 237) respectively after the procedure. The post donation PLT ct reduced to < 100x109/L (range 80-100) in five donors (N = 5/237, Amicus). The pre donation PLT ct in them was 150-200x109/L. Collection efficiency (percent) of Amicus (79.3) was better as compared to the other two machines (CS: 62.5, Cobe: 57.5). PC collected on Cobe spectra had <1x106 WBC. The donor pre donation PLT levels had a positive correlation to the product PLT yield (r = 0.30, P = 0.000).
Conclusion: Monitoring donor blood counts helps to avoid pheresis induced adverse events. A cautious approach is necessary in donors whose pre donation PLT ct is 150-200x109/L. The main variable in PLT yield is donor PLT ct (pre donation). High collection efficiency is a direct measure of an optimally functioning cell separator.
Sharma S, Bundas S, Prinja N, Sharma A, Narain R Asian J Transfus Sci. 2025; 18(2):252-256.
PMID: 39822666 PMC: 11734784. DOI: 10.4103/ajts.ajts_104_21.
Ashok C, Mahto S, Kumari S, Kumar A, Deepankar , Vidyapati Cureus. 2024; 16(6):e61510.
PMID: 38962593 PMC: 11221759. DOI: 10.7759/cureus.61510.
Syal N, Kukar N, Arora H, Kaur A, Handa A, Maharishi R J Family Med Prim Care. 2022; 11(4):1489-1492.
PMID: 35516708 PMC: 9067219. DOI: 10.4103/jfmpc.jfmpc_1409_21.
Effect of double dose plateletpheresis on target yield and donor platelet recovery.
Chopra S, Kaur P, Bedi R, Kaur G Hematol Transfus Cell Ther. 2021; 45(1):16-24.
PMID: 34294601 PMC: 9938487. DOI: 10.1016/j.htct.2021.05.002.
Das S, Sen S, Zaman R, Biswas R Indian J Hematol Blood Transfus. 2021; 37(1):134-139.
PMID: 33707846 PMC: 7900306. DOI: 10.1007/s12288-020-01337-1.